ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Novartis Ag Basel Namen Akt (PK)

Novartis Ag Basel Namen Akt (PK) (NVSEF)

110.995
0.00
(0.00%)
Closed 19 March 7:00AM

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 50.14B53.17B50.49B49.9B52.88B51.83B54.11B51.72B
Operating Income 9.74B14.61B9.82B10.83B27.03B9.19B10.02B14.51B
Pre Tax Income 9B13.84B9B9.88B26.14B8.37B9.33B13.64B
Net Income 7.7B12.61B11.73B8.07B24.02B6.96B14.85B11.94B
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 3.2345.3095.0373.47810.4493.1857.0465.856
EBIT 9.75B14.61B9.82B10.83B27.03B9.19B10.02B14.51B
EBITDA 15.85B21.34B15.68B17.3B33.24B16.38B18.31B19.68B